09.11.24
Weifang, Shandong, China
www.jofo.com.cn
2023 Nonwovens Sales: $300 million
Key Personnel
Minzhong Zhao, chairman; John Cai, CEO; Michael Wong, Senior VP- sales; Sven Krister Erlandsson, vice president, - R&D & BD
Plants
Weifang-Shandong, China; Guangzhou-Guangdong, China; Wuxi-Jiangsu, China; Al-Ahsa, Saudi Arabia; Rabigh, Saudi Arabia; Rayong, Thailand
Processes
Spunmelt, spunbond, needlepunch, air through bonded, Joform wipes, converted medical products
Major Markets
Medical, hygiene, geotextiles, automotive, furniture, wipes
Jofo Nonwovens continues to benefit from a globalization strategy started a few years ago that has included the acquisition of a Saudi Arabian spunmelt manufacturer and a Hong Kong-based wipes converter as well as investments within China.
Jofo acquired a 70% stake in SAAF, including two sites in Saudi Arabia, in July 2021, a move that not only gave the company its first operation outside of China but also increased its exposure to the global medical and hygiene markets. Not long after the acquisition, Jofo installed a medical wrap converting line at one of the SAAF sites, allowing it to supply finished goods to the medical market.
Back in Asia, Jofo’s partnership with Soshio Industrial Co., a contract manufacturer for wipes maker Rockline Industries, is allowing the company to expand into finished product manufacturing with its Joform technology which develops substrate material without water using primarily pulp to create green alternatives for both the manufacturer and the final producer. Joform materials are made using P&G’s Phantom technology, of which Jofo is a licensed supplier.
Meanwhile, within its local market, China, Jofo has expanded a spunmelt operation—acquired from PFNonwovens in 2019—with the addition of a new Reicofil 5 line in its Wuxi, China, facility. Products made on this line provide superior performance for the medical fabric field including much-improved quality for barrier performance and comfort is achieved.
The Reicofil technology combined with Jofo’s developments in raw materials and technology allow the company to create superior comfort and protection at cost structure that is attractive to the medical markets.
www.jofo.com.cn
2023 Nonwovens Sales: $300 million
Key Personnel
Minzhong Zhao, chairman; John Cai, CEO; Michael Wong, Senior VP- sales; Sven Krister Erlandsson, vice president, - R&D & BD
Plants
Weifang-Shandong, China; Guangzhou-Guangdong, China; Wuxi-Jiangsu, China; Al-Ahsa, Saudi Arabia; Rabigh, Saudi Arabia; Rayong, Thailand
Processes
Spunmelt, spunbond, needlepunch, air through bonded, Joform wipes, converted medical products
Major Markets
Medical, hygiene, geotextiles, automotive, furniture, wipes
Jofo Nonwovens continues to benefit from a globalization strategy started a few years ago that has included the acquisition of a Saudi Arabian spunmelt manufacturer and a Hong Kong-based wipes converter as well as investments within China.
Jofo acquired a 70% stake in SAAF, including two sites in Saudi Arabia, in July 2021, a move that not only gave the company its first operation outside of China but also increased its exposure to the global medical and hygiene markets. Not long after the acquisition, Jofo installed a medical wrap converting line at one of the SAAF sites, allowing it to supply finished goods to the medical market.
Back in Asia, Jofo’s partnership with Soshio Industrial Co., a contract manufacturer for wipes maker Rockline Industries, is allowing the company to expand into finished product manufacturing with its Joform technology which develops substrate material without water using primarily pulp to create green alternatives for both the manufacturer and the final producer. Joform materials are made using P&G’s Phantom technology, of which Jofo is a licensed supplier.
Meanwhile, within its local market, China, Jofo has expanded a spunmelt operation—acquired from PFNonwovens in 2019—with the addition of a new Reicofil 5 line in its Wuxi, China, facility. Products made on this line provide superior performance for the medical fabric field including much-improved quality for barrier performance and comfort is achieved.
The Reicofil technology combined with Jofo’s developments in raw materials and technology allow the company to create superior comfort and protection at cost structure that is attractive to the medical markets.
